Evaluating the use of paracetamol to prevent fasting headache during the first week of Ramadan: A randomized, open-label, clinical trial.

Background: Fasting headaches frequently occur during the first few days of Ramadan, and treatment is challenging because of fasting.

Objective: This study aimed to evaluate the effect of extended-release paracetamol on preventing fasting headaches.

Methods: A randomized, open-label clinical trial investigated the efficacy of extended-release paracetamol at a daily dose of 1330 mg in preventing fasting headache.